Drugs / G1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00239187 | Sep 2005 → Jan 2007 | type 2 diabetes mellitus | OPKO Health, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00239148 | Jun 2005 → Dec 2006 | type 1 diabetes mellitus | OPKO Health, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00239187 ↗ |
| Route | Subcutaneous | “once daily subcutaneous injections of E1 plus G1, as separate injections” NCT00239148 ↗ |